L-Varlock Cage/Trial Implant Holder
Recall Z-1461-2017, part of FDA recall event 76494. See Kiscomedica's company page.
Kiscomedica S.A. started this Class II device recall on Jan 11, 2017 (voluntary: firm initiated); FDA lists it as terminated.
- Classification: Class II
- Started: Jan 11, 2017
- Status: Terminated
Firm received a complaint of the tip holder breaking during use.
- Product
- L-Varlock Cage/Trial Implant Holder, Reference HD0060, Kisco International, France. Product Usage: The L-Varlock Lumbar Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). L-Varlock Lumbar implants are to be used with autogenous bone graft and implanted via an open posterior approach. L-Varlock Lumbar implant is to be used with supplemental fixation. Patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.
- Quantity
- 13 units
- Lots and codes
- Batch number: 15486
- Distribution
- Worldwide Distribution - US Nationwide in the states of MO and country of Switzerland.
- Recalling firm
- Kiscomedica S.A., Saint Priest, N/A, France
- How the firm notified
- Letter
- FDA classified
- Mar 14, 2017
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports